Concepedia

Kazi Nahar

KN

Statistics

Publications

8

Citations

201

H-Index

8

Active since

2015

Affiliations

The University of Sydney(Current)

Melanoma Institute Australia

Royal North Shore Hospital

Royal Prince Alfred Hospital

Westmead Hospital

Kazi Nahar is an author at The University of Sydney specializing in radiation oncology, oncology, and medicine.

ORCID

Top concepts

Publications per year

2015–2022

8

Publications

8

Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

Grace H. Attrill, C. Owen, Tasnia Ahmed et al. · Journal for ImmunoTherapy of Cancer · 2022 · 48 citations · Full text

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

Kazi Nahar, Robert V. Rawson, Tasnia Ahmed et al. · Journal for ImmunoTherapy of Cancer · 2020 · 41 citations · Full text

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

Sebastian Hultin, Kazi Nahar, Alexander M. Menzies et al. · BMC Nephrology · 2020 · 31 citations · Full text

Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis

Sarah C. Sasson, John Zaunders, Kazi Nahar et al. · Clinical & Experimental Immunology · 2020 · 25 citations · Full text

Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor‐positive breast cancer

Aaron C. Tan, Bob T. Li, Kazi Nahar et al. · Asia-Pacific Journal of Clinical Oncology · 2017 · 16 citations · Full text

1–5 of 8